Home » Topics » Regulatory

Regulatory
RSS

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

ESI Lederle launches generic acyclovir

April 29, 1997

FDA approves new labeling for Bristol-Myers Squibb's Pravachol

April 29, 1997

Mylan Laboratories's Acyclovir receives FDA approval

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Teva receives FDA approval for antihypertensive generic

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...